HAART, or Highly Active Antiretroviral Therapy has halved the annual number of new HIV diagnoses since 1996, when the therapy was first introduced, say Canadian researchers in a study published in the peer-reviewed medical journal The Lancet. Study findings are being presented at the forthcoming AIDS Society conference in Vienna. Professor Julio Montaner, Director, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, and team reported that for every 100 patients placed on HAART, new diagnoses of HIV dropped by 3%... 
More...
More...